These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31804513)

  • 1. Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research.
    Yang K; Zeng L; Bao T; Long Z; Jin B
    Sci Rep; 2019 Dec; 9(1):18420. PubMed ID: 31804513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial.
    Bahramrezaie M; Amidi F; Aleyasin A; Saremi A; Aghahoseini M; Brenjian S; Khodarahmian M; Pooladi A
    J Assist Reprod Genet; 2019 Aug; 36(8):1701-1712. PubMed ID: 31327131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.
    Pourteymour Fard Tabrizi F; Hajizadeh-Sharafabad F; Vaezi M; Jafari-Vayghan H; Alizadeh M; Maleki V
    J Ovarian Res; 2020 Jan; 13(1):11. PubMed ID: 32005271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
    Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
    J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome Rats.
    Rubio-Ruiz ME; Guarner-Lans V; Cano-Martínez A; Díaz-Díaz E; Manzano-Pech L; Gamas-Magaña A; Castrejón-Tellez V; Tapia-Cortina C; Pérez-Torres I
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.
    Ergenoglu M; Yildirim N; Yildirim AG; Yeniel O; Erbas O; Yavasoglu A; Taskiran D; Karadadas N
    Reprod Sci; 2015 Aug; 22(8):942-7. PubMed ID: 25667201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model.
    Zhang N; Zhuang L; Gai S; Shan Y; Wang S; Li F; Chen L; Zhao D; Liu X
    Gynecol Endocrinol; 2021 Apr; 37(4):337-341. PubMed ID: 32851887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome.
    Cano-Martínez A; Bautista-Pérez R; Castrejón-Téllez V; Carreón-Torres E; Pérez-Torres I; Díaz-Díaz E; Flores-Estrada J; Guarner-Lans V; Rubio-Ruíz ME
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
    Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
    J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment.
    Wang Z; Zhai D; Zhang D; Bai L; Yao R; Yu J; Cheng W; Yu C
    Reprod Sci; 2017 May; 24(5):682-690. PubMed ID: 27634381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS).
    Neisy A; Zal F; Seghatoleslam A; Alaee S
    Reprod Fertil Dev; 2019 Jan; 31(2):315-323. PubMed ID: 30103849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Role of Resveratrol and Quercetin on Aortic Fibroblasts of Psammomys obesus After Oxidative Stress by Hydrogen Peroxide.
    Boumaza S; Belkebir A; Neggazi S; Sahraoui H; Berdja S; Smail L; Benazzoug Y; Kacimi G; Aouichat Bouguerra S
    Am J Ther; 2018; 25(3):e299-e313. PubMed ID: 26766292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs.
    Wang M; An K; Huang J; Mprah R; Ding H
    Front Endocrinol (Lausanne); 2023; 14():1193992. PubMed ID: 37745699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
    Wei L; Xin C; Wang W; Hao C
    Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Resveratrol/Quercetin Mixture on the Reversion of Hypertension Induced by a Short-Term Exposure to High Sucrose Levels Near Weaning and a Long-Term Exposure That Leads to Metabolic Syndrome in Rats.
    Castrejón-Téllez V; Villegas-Romero M; Rubio-Ruiz ME; Pérez-Torres I; Carreón-Torres E; Díaz-Díaz E; Guarner-Lans V
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers.
    Brenjian S; Moini A; Yamini N; Kashani L; Faridmojtahedi M; Bahramrezaie M; Khodarahmian M; Amidi F
    Am J Reprod Immunol; 2020 Jan; 83(1):e13186. PubMed ID: 31483910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.
    Selen Alpergin ES; Bolandnazar Z; Sabatini M; Rogowski M; Chiellini G; Zucchi R; Assadi-Porter FM
    Physiol Rep; 2017 Jan; 5(1):. PubMed ID: 28082426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: A comprehensive systematic review of clinical, animal and in vitro studies.
    Karimi A; Tutunchi H; Naeini F; Vajdi M; Mobasseri M; Najafipour F
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):935-949. PubMed ID: 35778955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing.
    Fu LL; Xu Y; Li DD; Dai XW; Xu X; Zhang JS; Ming H; Zhang XY; Zhang GQ; Ma YL; Zheng LW
    Gene; 2018 May; 657():19-29. PubMed ID: 29505837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.